BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Hirano M, Garone C, Quinzii CM. CoQ(10) deficiencies and MNGIE: two treatable mitochondrial disorders. Biochim Biophys Acta 2012;1820:625-31. [PMID: 22274133 DOI: 10.1016/j.bbagen.2012.01.006] [Cited by in Crossref: 66] [Cited by in F6Publishing: 54] [Article Influence: 6.6] [Reference Citation Analysis]
Number Citing Articles
1 Wang Y, Hekimi S. Mitochondrial respiration without ubiquinone biosynthesis. Hum Mol Genet 2013;22:4768-83. [PMID: 23847050 DOI: 10.1093/hmg/ddt330] [Cited by in Crossref: 25] [Cited by in F6Publishing: 22] [Article Influence: 2.8] [Reference Citation Analysis]
2 Widmeier E, Airik M, Hugo H, Schapiro D, Wedel J, Ghosh CC, Nakayama M, Schneider R, Awad AM, Nag A, Cho J, Schueler M, Clarke CF, Airik R, Hildebrandt F. Treatment with 2,4-Dihydroxybenzoic Acid Prevents FSGS Progression and Renal Fibrosis in Podocyte-Specific Coq6 Knockout Mice. J Am Soc Nephrol 2019:ASN. [PMID: 30737270 DOI: 10.1681/ASN.2018060625] [Cited by in Crossref: 17] [Cited by in F6Publishing: 12] [Article Influence: 5.7] [Reference Citation Analysis]
3 Peralta S, Garcia S, Yin HY, Arguello T, Diaz F, Moraes CT. Sustained AMPK activation improves muscle function in a mitochondrial myopathy mouse model by promoting muscle fiber regeneration. Hum Mol Genet 2016;25:3178-91. [PMID: 27288451 DOI: 10.1093/hmg/ddw167] [Cited by in Crossref: 16] [Cited by in F6Publishing: 15] [Article Influence: 2.7] [Reference Citation Analysis]
4 DiMauro S, Schon EA, Carelli V, Hirano M. The clinical maze of mitochondrial neurology. Nat Rev Neurol 2013;9:429-44. [PMID: 23835535 DOI: 10.1038/nrneurol.2013.126] [Cited by in Crossref: 210] [Cited by in F6Publishing: 178] [Article Influence: 23.3] [Reference Citation Analysis]
5 Hurko O. Drug development for rare mitochondrial disorders. Neurotherapeutics 2013;10:286-306. [PMID: 23430661 DOI: 10.1007/s13311-013-0179-4] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 0.8] [Reference Citation Analysis]
6 Koene S, Jansen M, Verhaak CM, De Vrueh RL, De Groot IJ, Smeitink JA. Towards the harmonization of outcome measures in children with mitochondrial disorders. Dev Med Child Neurol 2013;55:698-706. [PMID: 23489006 DOI: 10.1111/dmcn.12119] [Cited by in Crossref: 6] [Cited by in F6Publishing: 13] [Article Influence: 0.7] [Reference Citation Analysis]
7 Di Meo I, Lamperti C, Tiranti V. Mitochondrial diseases caused by toxic compound accumulation: from etiopathology to therapeutic approaches. EMBO Mol Med. 2015;7:1257-1266. [PMID: 26194912 DOI: 10.15252/emmm.201505040] [Cited by in Crossref: 25] [Cited by in F6Publishing: 26] [Article Influence: 4.2] [Reference Citation Analysis]
8 Itkonen O, Suomalainen A, Turpeinen U. Mitochondrial coenzyme Q10 determination by isotope-dilution liquid chromatography-tandem mass spectrometry. Clin Chem 2013;59:1260-7. [PMID: 23640978 DOI: 10.1373/clinchem.2012.200196] [Cited by in Crossref: 15] [Cited by in F6Publishing: 13] [Article Influence: 1.7] [Reference Citation Analysis]
9 Wang Y, Oxer D, Hekimi S. Mitochondrial function and lifespan of mice with controlled ubiquinone biosynthesis. Nat Commun 2015;6:6393. [PMID: 25744659 DOI: 10.1038/ncomms7393] [Cited by in Crossref: 65] [Cited by in F6Publishing: 54] [Article Influence: 9.3] [Reference Citation Analysis]
10 Chen FL, Chang PS, Lin YC, Lin PT. A Pilot Clinical Study of Liquid Ubiquinol Supplementation on Cardiac Function in Pediatric Dilated Cardiomyopathy. Nutrients 2018;10:E1697. [PMID: 30405022 DOI: 10.3390/nu10111697] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
11 Itkonen O, Turpeinen U. Mitochondrial coenzyme Q10 determination via isotope dilution liquid chromatography tandem mass spectrometry. Methods Mol Biol 2015;1264:271-8. [PMID: 25631021 DOI: 10.1007/978-1-4939-2257-4_24] [Reference Citation Analysis]
12 Saada A. Mitochondria: mitochondrial OXPHOS (dys) function ex vivo--the use of primary fibroblasts. Int J Biochem Cell Biol 2014;48:60-5. [PMID: 24412346 DOI: 10.1016/j.biocel.2013.12.010] [Cited by in Crossref: 28] [Cited by in F6Publishing: 22] [Article Influence: 3.5] [Reference Citation Analysis]
13 Bruder E, Rougemont A, Furlano R, Schneider J, Mayr J, Haecker F, Beier K, Schneider J, Weber P, Berberich T, Cathomas G, Meier-ruge W. Motilitätsstörungen des Ösophagus. Pathologe 2013;34:118-32. [DOI: 10.1007/s00292-012-1727-0] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.2] [Reference Citation Analysis]
14 Peralta S, Torraco A, Iommarini L, Diaz F. Mitochondrial Diseases Part III: Therapeutic interventions in mouse models of OXPHOS deficiencies. Mitochondrion 2015;23:71-80. [PMID: 25638392 DOI: 10.1016/j.mito.2015.01.007] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 1.1] [Reference Citation Analysis]
15 Bax BE, Bain MD, Scarpelli M, Filosto M, Tonin P, Moran N. Clinical and biochemical improvements in a patient with MNGIE following enzyme replacement. Neurology 2013;81:1269-71. [PMID: 23966250 DOI: 10.1212/WNL.0b013e3182a6cb4b] [Cited by in Crossref: 54] [Cited by in F6Publishing: 29] [Article Influence: 6.0] [Reference Citation Analysis]
16 Pagano G, Talamanca AA, Castello G, Cordero MD, d'Ischia M, Gadaleta MN, Pallardó FV, Petrović S, Tiano L, Zatterale A. Oxidative stress and mitochondrial dysfunction across broad-ranging pathologies: toward mitochondria-targeted clinical strategies. Oxid Med Cell Longev 2014;2014:541230. [PMID: 24876913 DOI: 10.1155/2014/541230] [Cited by in Crossref: 82] [Cited by in F6Publishing: 77] [Article Influence: 10.3] [Reference Citation Analysis]
17 Milone M, Wong L. Diagnosis of mitochondrial myopathies. Molecular Genetics and Metabolism 2013;110:35-41. [DOI: 10.1016/j.ymgme.2013.07.007] [Cited by in Crossref: 57] [Cited by in F6Publishing: 37] [Article Influence: 6.3] [Reference Citation Analysis]
18 Turkowicz MJ, Karpińska J. Analytical problems with the determination of coenzyme Q10 in biological samples. Biofactors 2013;39:176-85. [PMID: 23303649 DOI: 10.1002/biof.1058] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 0.9] [Reference Citation Analysis]
19 Benureau A, Meyer P, Maillet O, Leboucq N, Legras S, Jeziorski E, Fournier-Favre S, Jeandel C, Gaignard P, Slama A, Rivier F, Roubertie A, Carneiro M. [Mitochondrial neurogastrointestinal encephalopathy disease]. Arch Pediatr 2014;21:1370-4. [PMID: 25282463 DOI: 10.1016/j.arcped.2014.08.006] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
20 Barcelos I, Shadiack E, Ganetzky RD, Falk MJ. Mitochondrial medicine therapies: rationale, evidence, and dosing guidelines. Curr Opin Pediatr 2020;32:707-18. [PMID: 33105273 DOI: 10.1097/MOP.0000000000000954] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 7.0] [Reference Citation Analysis]
21 Koene S, Wortmann SB, de Vries MC, Jonckheere AI, Morava E, de Groot IJ, Smeitink JA. Developing outcome measures for pediatric mitochondrial disorders: Which complaints and limitations are most burdensome to patients and their parents? Mitochondrion 2013;13:15-24. [DOI: 10.1016/j.mito.2012.11.002] [Cited by in Crossref: 28] [Cited by in F6Publishing: 25] [Article Influence: 3.1] [Reference Citation Analysis]
22 Schiff M, Bénit P, Jacobs HT, Vockley J, Rustin P. Therapies in inborn errors of oxidative metabolism. Trends Endocrinol Metab 2012;23:488-95. [PMID: 22633959 DOI: 10.1016/j.tem.2012.04.006] [Cited by in Crossref: 14] [Cited by in F6Publishing: 13] [Article Influence: 1.4] [Reference Citation Analysis]
23 Lu B, Qiu Y, Qi S, Wang J. A convenient two-step synthesis of Coenzyme Q 1. Journal of Chemical Research 2019;43:553-6. [DOI: 10.1177/1747519819876524] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
24 Alcázar-Fabra M, Navas P, Brea-Calvo G. Coenzyme Q biosynthesis and its role in the respiratory chain structure. Biochim Biophys Acta 2016;1857:1073-8. [PMID: 26970214 DOI: 10.1016/j.bbabio.2016.03.010] [Cited by in Crossref: 54] [Cited by in F6Publishing: 46] [Article Influence: 9.0] [Reference Citation Analysis]
25 Baertling F, Rodenburg RJ, Schaper J, Smeitink JA, Koopman WJ, Mayatepek E, Morava E, Distelmaier F. A guide to diagnosis and treatment of Leigh syndrome. J Neurol Neurosurg Psychiatry. 2014;85:257-265. [PMID: 23772060 DOI: 10.1136/jnnp-2012-304426] [Cited by in Crossref: 111] [Cited by in F6Publishing: 89] [Article Influence: 12.3] [Reference Citation Analysis]
26 Bottani E, Lamperti C, Prigione A, Tiranti V, Persico N, Brunetti D. Therapeutic Approaches to Treat Mitochondrial Diseases: "One-Size-Fits-All" and "Precision Medicine" Strategies. Pharmaceutics 2020;12:E1083. [PMID: 33187380 DOI: 10.3390/pharmaceutics12111083] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 5.0] [Reference Citation Analysis]
27 Wang Y, Hekimi S. Understanding Ubiquinone. Trends in Cell Biology 2016;26:367-78. [DOI: 10.1016/j.tcb.2015.12.007] [Cited by in Crossref: 93] [Cited by in F6Publishing: 79] [Article Influence: 15.5] [Reference Citation Analysis]
28 Russell OM, Gorman GS, Lightowlers RN, Turnbull DM. Mitochondrial Diseases: Hope for the Future. Cell 2020;181:168-88. [PMID: 32220313 DOI: 10.1016/j.cell.2020.02.051] [Cited by in Crossref: 57] [Cited by in F6Publishing: 52] [Article Influence: 28.5] [Reference Citation Analysis]
29 Hedman E, Itkonen O. Mitochondrial Coenzyme Q10 Determination Via Isotope Dilution Liquid Chromatography -Tandem Mass Spectrometry. Methods Mol Biol 2021;2275:329-39. [PMID: 34118048 DOI: 10.1007/978-1-0716-1262-0_21] [Reference Citation Analysis]
30 Scarpelli M, Todeschini A, Volonghi I, Padovani A, Filosto M. Mitochondrial diseases: advances and issues. Appl Clin Genet 2017;10:21-6. [PMID: 28243136 DOI: 10.2147/TACG.S94267] [Cited by in Crossref: 13] [Cited by in F6Publishing: 5] [Article Influence: 2.6] [Reference Citation Analysis]
31 Chapman TP, Hadley G, Fratter C, Cullen SN, Bax BE, Bain MD, Sapsford RA, Poulton J, Travis SP. Unexplained gastrointestinal symptoms: think mitochondrial disease. Dig Liver Dis 2014;46:1-8. [PMID: 23768727 DOI: 10.1016/j.dld.2013.04.008] [Cited by in Crossref: 22] [Cited by in F6Publishing: 18] [Article Influence: 2.4] [Reference Citation Analysis]
32 Bax BE. Mitochondrial neurogastrointestinal encephalomyopathy: approaches to diagnosis and treatment. J Transl Genet Genom 2020;4:1-16. [PMID: 32914088 DOI: 10.20517/jtgg.2020.08] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.7] [Reference Citation Analysis]
33 Bennett NK, Nguyen MK, Darch MA, Nakaoka HJ, Cousineau D, Ten Hoeve J, Graeber TG, Schuelke M, Maltepe E, Kampmann M, Mendelsohn BA, Nakamura JL, Nakamura K. Defining the ATPome reveals cross-optimization of metabolic pathways. Nat Commun 2020;11:4319. [PMID: 32859923 DOI: 10.1038/s41467-020-18084-6] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
34 Che R, Yuan Y, Huang S, Zhang A. Mitochondrial dysfunction in the pathophysiology of renal diseases. American Journal of Physiology-Renal Physiology 2014;306:F367-78. [DOI: 10.1152/ajprenal.00571.2013] [Cited by in Crossref: 207] [Cited by in F6Publishing: 197] [Article Influence: 25.9] [Reference Citation Analysis]
35 Wang HF, Wang J, Wang YL, Fan JJ, Mo GL, Gong FY, Chai ZM, Zhang J, Meng HX, Li CX, Guo JH, Pu CQ. A novel thymidine phosphorylase mutation in a Chinese MNGIE patient. Acta Neurol Belg 2017;117:259-67. [PMID: 27709505 DOI: 10.1007/s13760-016-0701-7] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.7] [Reference Citation Analysis]
36 McInnes J. Mitochondrial-associated metabolic disorders: foundations, pathologies and recent progress. Nutr Metab (Lond) 2013;10:63. [PMID: 24499129 DOI: 10.1186/1743-7075-10-63] [Cited by in Crossref: 19] [Cited by in F6Publishing: 19] [Article Influence: 2.1] [Reference Citation Analysis]
37 Ronchi D, Caporali L, Manenti GF, Meneri M, Mohamed S, Bordoni A, Tagliavini F, Contin M, Piga D, Sciacco M, Saetti C, Carelli V, Comi GP. TYMP Variants Result in Late-Onset Mitochondrial Myopathy With Altered Muscle Mitochondrial DNA Homeostasis. Front Genet 2020;11:860. [PMID: 32849836 DOI: 10.3389/fgene.2020.00860] [Reference Citation Analysis]
38 Pesini A, Hidalgo-gutierrez A, Quinzii CM. Mechanisms and Therapeutic Effects of Benzoquinone Ring Analogs in Primary CoQ Deficiencies. Antioxidants 2022;11:665. [DOI: 10.3390/antiox11040665] [Reference Citation Analysis]
39 Dominy JE, Puigserver P. Mitochondrial biogenesis through activation of nuclear signaling proteins. Cold Spring Harb Perspect Biol 2013;5:a015008. [PMID: 23818499 DOI: 10.1101/cshperspect.a015008] [Cited by in Crossref: 115] [Cited by in F6Publishing: 111] [Article Influence: 12.8] [Reference Citation Analysis]
40 Barcelos IP, Haas RH. CoQ10 and Aging. Biology (Basel) 2019;8:E28. [PMID: 31083534 DOI: 10.3390/biology8020028] [Cited by in Crossref: 22] [Cited by in F6Publishing: 17] [Article Influence: 7.3] [Reference Citation Analysis]
41 Kripps K, Nakayuenyongsuk W, Shayota BJ, Berquist W, Gomez-Ospina N, Esquivel CO, Concepcion W, Sampson JB, Cristin DJ, Jackson WE, Gilliland S, Pomfret EA, Kueht ML, Pettit RW, Sherif YA, Emrick LT, Elsea SH, Himes R, Hirano M, Van Hove JLK, Scaglia F, Enns GM, Larson AA. Successful liver transplantation in mitochondrial neurogastrointestinal encephalomyopathy (MNGIE). Mol Genet Metab 2020;130:58-64. [PMID: 32173240 DOI: 10.1016/j.ymgme.2020.03.001] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 5.5] [Reference Citation Analysis]
42 Suárez-Rivero JM, Pastor-Maldonado CJ, Povea-Cabello S, Álvarez-Córdoba M, Villalón-García I, Talaverón-Rey M, Suárez-Carrillo A, Munuera-Cabeza M, Sánchez-Alcázar JA. Mitochondria and Antibiotics: For Good or for Evil? Biomolecules 2021;11:1050. [PMID: 34356674 DOI: 10.3390/biom11071050] [Reference Citation Analysis]
43 Sukjamnong S, Chan YL, Zakarya R, Nguyen LT, Anwer AG, Zaky AA, Santiyanont R, Oliver BG, Goldys E, Pollock CA, Chen H, Saad S. MitoQ supplementation prevent long-term impact of maternal smoking on renal development, oxidative stress and mitochondrial density in male mice offspring. Sci Rep 2018;8:6631. [PMID: 29700332 DOI: 10.1038/s41598-018-24949-0] [Cited by in Crossref: 20] [Cited by in F6Publishing: 20] [Article Influence: 5.0] [Reference Citation Analysis]
44 Sharp J, Farha S, Park MM, Comhair SA, Lundgrin EL, Tang WH, Bongard RD, Merker MP, Erzurum SC. Coenzyme Q supplementation in pulmonary arterial hypertension. Redox Biol 2014;2:884-91. [PMID: 25180165 DOI: 10.1016/j.redox.2014.06.010] [Cited by in Crossref: 17] [Cited by in F6Publishing: 15] [Article Influence: 2.1] [Reference Citation Analysis]
45 Ziats CA, Rennert OM, Ziats MN. Toward a Pathway-Driven Clinical-Molecular Framework for Classifying Autism Spectrum Disorders. Pediatr Neurol 2019;98:46-52. [PMID: 31272785 DOI: 10.1016/j.pediatrneurol.2019.05.004] [Cited by in Crossref: 2] [Article Influence: 0.7] [Reference Citation Analysis]
46 Lu M, Zhou Y, Wang Z, Xia Z, Ren J, Guo Q. Clinical phenotype, in silico and biomedical analyses, and intervention for an East Asian population-specific c.370G>A (p.G124S) COQ4 mutation in a Chinese family with CoQ10 deficiency-associated Leigh syndrome. J Hum Genet 2019;64:297-304. [PMID: 30659264 DOI: 10.1038/s10038-019-0563-y] [Cited by in Crossref: 5] [Cited by in F6Publishing: 7] [Article Influence: 1.7] [Reference Citation Analysis]
47 Pierrel F. Impact of Chemical Analogs of 4-Hydroxybenzoic Acid on Coenzyme Q Biosynthesis: From Inhibition to Bypass of Coenzyme Q Deficiency. Front Physiol 2017;8:436. [PMID: 28690551 DOI: 10.3389/fphys.2017.00436] [Cited by in Crossref: 23] [Cited by in F6Publishing: 21] [Article Influence: 4.6] [Reference Citation Analysis]
48 Schulz AM, Haynes CM. UPR(mt)-mediated cytoprotection and organismal aging. Biochim Biophys Acta 2015;1847:1448-56. [PMID: 25857997 DOI: 10.1016/j.bbabio.2015.03.008] [Cited by in Crossref: 74] [Cited by in F6Publishing: 68] [Article Influence: 10.6] [Reference Citation Analysis]
49 Tabata S, Yamamoto M, Goto H, Hirayama A, Ohishi M, Kuramoto T, Mitsuhashi A, Ikeda R, Haraguchi M, Kawahara K, Shinsato Y, Minami K, Saijo A, Hanibuchi M, Nishioka Y, Sone S, Esumi H, Tomita M, Soga T, Furukawa T, Akiyama SI. Thymidine Catabolism as a Metabolic Strategy for Cancer Survival. Cell Rep 2017;19:1313-21. [PMID: 28514652 DOI: 10.1016/j.celrep.2017.04.061] [Cited by in Crossref: 23] [Cited by in F6Publishing: 19] [Article Influence: 5.8] [Reference Citation Analysis]
50 Kerr DS. Review of clinical trials for mitochondrial disorders: 1997-2012. Neurotherapeutics 2013;10:307-19. [PMID: 23361264 DOI: 10.1007/s13311-013-0176-7] [Cited by in Crossref: 75] [Cited by in F6Publishing: 61] [Article Influence: 8.3] [Reference Citation Analysis]
51 Quaglia A, Roberts EA, Torbenson M. Developmental and Inherited Liver Disease. Macsween's Pathology of the Liver. Elsevier; 2018. pp. 111-274. [DOI: 10.1016/b978-0-7020-6697-9.00003-0] [Cited by in Crossref: 4] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
52 Torraco A, Peralta S, Iommarini L, Diaz F. Mitochondrial Diseases Part I: mouse models of OXPHOS deficiencies caused by defects in respiratory complex subunits or assembly factors. Mitochondrion 2015;21:76-91. [PMID: 25660179 DOI: 10.1016/j.mito.2015.01.009] [Cited by in Crossref: 29] [Cited by in F6Publishing: 27] [Article Influence: 4.1] [Reference Citation Analysis]
53 Kornblum C. Therapie mitochondrialer Erkrankungen. Medizinische Genetik 2012;24:187-92. [DOI: 10.1007/s11825-012-0347-7] [Reference Citation Analysis]
54 Pareyson D, Piscosquito G, Moroni I, Salsano E, Zeviani M. Peripheral neuropathy in mitochondrial disorders. Lancet Neurol 2013;12:1011-24. [PMID: 24050734 DOI: 10.1016/S1474-4422(13)70158-3] [Cited by in Crossref: 59] [Cited by in F6Publishing: 22] [Article Influence: 6.6] [Reference Citation Analysis]
55 Molleston JP, Sokol RJ, Karnsakul W, Miethke A, Horslen S, Magee JC, Romero R, Squires RH, Van Hove JL. Evaluation of the child with suspected mitochondrial liver disease. J Pediatr Gastroenterol Nutr. 2013;57:269-276. [PMID: 23783016 DOI: 10.1097/mpg.0b013e31829ef67a] [Cited by in Crossref: 29] [Cited by in F6Publishing: 8] [Article Influence: 3.6] [Reference Citation Analysis]
56 Wang Y, Hekimi S. The Complexity of Making Ubiquinone. Trends in Endocrinology & Metabolism 2019;30:929-43. [DOI: 10.1016/j.tem.2019.08.009] [Cited by in Crossref: 17] [Cited by in F6Publishing: 15] [Article Influence: 5.7] [Reference Citation Analysis]
57 Wang H, Han Y, Li S, Chen Y, Chen Y, Wang J, Zhang Y, Zhang Y, Wang J, Xia Y, Yuan J. Mitochondrial DNA Depletion Syndrome and Its Associated Cardiac Disease. Front Cardiovasc Med 2022;8:808115. [DOI: 10.3389/fcvm.2021.808115] [Reference Citation Analysis]
58 Mendelsohn BA, Bennett NK, Darch MA, Yu K, Nguyen MK, Pucciarelli D, Nelson M, Horlbeck MA, Gilbert LA, Hyun W, Kampmann M, Nakamura JL, Nakamura K. A high-throughput screen of real-time ATP levels in individual cells reveals mechanisms of energy failure. PLoS Biol 2018;16:e2004624. [PMID: 30148842 DOI: 10.1371/journal.pbio.2004624] [Cited by in Crossref: 23] [Cited by in F6Publishing: 24] [Article Influence: 5.8] [Reference Citation Analysis]
59 Lee WS, Sokol RJ. Mitochondrial hepatopathies: advances in genetics, therapeutic approaches, and outcomes. J Pediatr 2013;163:942-8. [PMID: 23810725 DOI: 10.1016/j.jpeds.2013.05.036] [Cited by in Crossref: 35] [Cited by in F6Publishing: 20] [Article Influence: 3.9] [Reference Citation Analysis]
60 Wang Y, Hekimi S. Molecular genetics of ubiquinone biosynthesis in animals. Crit Rev Biochem Mol Biol 2013;48:69-88. [PMID: 23190198 DOI: 10.3109/10409238.2012.741564] [Cited by in Crossref: 41] [Cited by in F6Publishing: 39] [Article Influence: 4.1] [Reference Citation Analysis]